ATYR · Categories · Form 4

ATYR - SEC Form 4 insider transactions

aTyr Pharma Inc. (ATYR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ATYR

• 80d
  President and CEO Shukla Sanjay converted options into 10,375 shares and sold $3,655 worth of shares (3,745 units at $0.98), increasing direct ownership by 5% to 153,553 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 80d
  Chief Financial Officer Broadfoot Jill Marie converted options into 3,750 shares and sold $1,521 worth of shares (1,558 units at $0.98), increasing direct ownership by 6% to 37,296 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 80d
  General Counsel Denyes Nancy converted options into 2,687 shares and sold $1,091 worth of shares (1,118 units at $0.98), increasing direct ownership by 5% to 33,124 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 107d
  SEC Form 4 filed by President and CEO Shukla Sanjay

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 107d
  SEC Form 4 filed by Chief Financial Officer Broadfoot Jill Marie

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 107d
  SEC Form 4 filed by General Counsel Denyes Nancy

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Zaknoen Sara

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Schimmel Paul

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Lucas Svetlana

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Gross Jane A

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Benevich Eric

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 359d
  SEC Form 4 filed by Director Coughlin Timothy

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 445d
  President and CEO Shukla Sanjay converted options into 10,375 shares, increasing direct ownership by 8% to 146,923 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 445d
  Chief Financial Officer Broadfoot Jill Marie converted options into 3,750 shares and sold $4,740 worth of shares (1,254 units at $3.78), increasing direct ownership by 9% to 31,763 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 445d
  General Counsel Denyes Nancy sold $3,398 worth of shares (899 units at $3.78) and converted options into 2,687 shares, increasing direct ownership by 7% to 26,555 units (SEC Form 4)

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 471d
  SEC Form 4 filed by President and CEO Shukla Sanjay

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 471d
  SEC Form 4 filed by Chief Financial Officer Broadfoot Jill Marie

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 471d
  SEC Form 4 filed by General Counsel Denyes Nancy

  4 - aTYR PHARMA INC (0001339970) (Issuer)
• 500d
  SEC Form 4 filed by Director Benevich Eric

  4 - aTYR PHARMA INC (0001339970) (Issuer)

Other ATYR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends